Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Progyny (PGNY)

Progyny: Director Fred Cohen will not stand for reelection at 2025 annual meeting

Neutral Impact 2 of 5 leadership Written later

Progyny director Dr. Fred E. Cohen told the board on April 9, 2025, that he will not seek reelection at the company's 2025 Annual Meeting of Stockholders. The filing says his decision did not involve any disagreement with the company on operations, policies or practices, and he will serve until his current term ends at that meeting.

Key points

  • Dr. Fred E. Cohen notified the board on April 9, 2025 of his decision not to stand for reelection.
  • He will remain a director through the end of his current term, which ends at the 2025 Annual Meeting of Stockholders.
  • The filing states the decision was not related to any disagreement with the company.

The filing

CompanyProgyny (PGNY)
Form8-K, current report
Filed with the SECApr 11, 2025, 9:20 AM ET
Accession number0001551306-25-000070

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:56 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 11, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.